Rigetti Computing shares slump on Q4 revenue miss

Rigetti Computing reported Q4 revenue of $1.87M versus analysts' $2.37M estimate, sending shares down ~9%, while reporting a smaller-than-expected loss of $0.03 per share (consensus -$0.05). Full-year revenue was $7.1M with non-GAAP net loss of $50.5M ($0.16/sh) and GAAP net loss of $216.2M ($0.70/sh); year-end cash and equivalents totaled $589.8M. Management highlighted technical progress — 99.9% two-qubit gate fidelity at 28 ns — and flagged potential March-quarter recognition of about $5.7M from Novera on-prem system sales and near-term deliveries (including a planned 108‑qubit deployment), while Jefferies kept a Hold rating and cut its price target to $20.

Analysis

Market structure: Rigetti’s revenue miss but strong cash ($589.8M) and announced on‑prem sales ($5.7M Novera recognition, $8.4M C‑DAC) signal a bifurcated market where early adopters (national labs, defense, large research orgs) and on‑prem system integrators win while pure cloud‑only offerings face delayed monetization. Competitively, wins for Rigetti’s roadmap (99.9% two‑qubit fidelity, 28ns) shift tactical advantage toward firms that can deliver low‑latency, on‑site QPUs; incumbents (IONQ, AWS/GOOGL/MSFT quantum services) retain scale but risk losing premium on‑prem customers. Limited supply of validated QPUs vs concentrated early demand implies pricing power for functioning units near term; equities volatility and option IV on small‑cap quantum names should remain elevated, while broader fixed income and FX are unlikely to move materially.

Risk assessment: Key tail risks include a failed 108‑qubit deployment (end‑March test), export/regulatory constraints on sensitive quantum components, and a need to raise capital if burn accelerates. Using reported non‑GAAP loss ~$50.5M and GAAP ~$216M, the cash position implies multi‑quarter runway under current spending but not under aggressive commercialization; a dilution event is medium probability if execution stalls. Time horizons: immediate (days) — headline‑driven volatility; short (weeks–months) — revenue recognition and 108‑qubit proof; long (2026–2027) — roadmap to >150 and >1,000 qubits hinges on sustained error‑rate improvements and partner deliveries.

Trade implications: Tactical long exposure to RGTI is milestone‑driven: positive catalysts are 108‑qubit deployment within 30 days and March‑quarter recognition of $5.7M Novera sales; failure to hit either should trigger downside defense. Options offer controlled upside: debit call spreads into Jun 2026 cap downside while preserving upside to H2 2026 system sales. Relative plays: pair RGTI vs IONQ to isolate execution; overweight cloud/enterprise vendors (GOOGL, MSFT) by rotating 1–2% from pure‑play quantum small caps to capture service aggregation.

Key Decisions for Investors

• Establish a tactical long position in RGTI equal to 2–3% of portfolio IF shares drop >10% intraday on the earnings headline; set a hard stop‑loss at 20% and a take‑profit target of +50% with review by 31‑Dec‑2026 to capture milestone upside (108‑qubit delivery by end‑March and >150 qubits by end‑2026).
• Buy a Jun‑2026 RGTI $10/$25 bull call spread sized to risk 0.5–1.0% of portfolio (defined max loss) to capture H1/H2 2026 system sale upside; roll or close if 108‑qubit deployment fails or implied vol spikes >40% above current levels.
• Implement a pair trade: long RGTI vs short IONQ (1:1 dollar‑neutral) sized 1% net exposure to express idiosyncratic execution upside for RGTI over next 6 months; unwind if RGTI misses the 108‑qubit demo or if RGTI cash falls below $450M.
• Reduce aggregated exposure to small‑cap pure‑play quantum names by 1–2% and redeploy into GOOGL and MSFT (add 0.5–1.0% each) over the next 30 days to capture platform/service capture if Rigetti execution stalls; revisit allocation after the March/April milestone window (30–60 days).